DrugPatentWatch Database Preview
Mayne Pharma Intl Company Profile
What is the competitive landscape for MAYNE PHARMA INTL, and what generic alternatives to MAYNE PHARMA INTL drugs are available?
MAYNE PHARMA INTL has two approved drugs.
There are four US patents protecting MAYNE PHARMA INTL drugs.
There are twenty-three patent family members on MAYNE PHARMA INTL drugs in twelve countries.
Summary for Mayne Pharma Intl
| International Patents: | 23 |
| US Patents: | 4 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
Drugs and US Patents for Mayne Pharma Intl
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mayne Pharma Intl | DORYX | doxycycline hyclate | CAPSULE, DELAYED RELEASE;ORAL | 050582-002 | Aug 13, 2001 | DISCN | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
| Mayne Pharma Intl | TOLSURA | itraconazole | CAPSULE;ORAL | 208901-001 | Dec 11, 2018 | RX | Yes | Yes | 9,272,046 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Mayne Pharma Intl | DORYX | doxycycline hyclate | CAPSULE, DELAYED RELEASE;ORAL | 050582-001 | Jul 22, 1985 | DISCN | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
| Mayne Pharma Intl | TOLSURA | itraconazole | CAPSULE;ORAL | 208901-001 | Dec 11, 2018 | RX | Yes | Yes | 8,771,739 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Mayne Pharma Intl | TOLSURA | itraconazole | CAPSULE;ORAL | 208901-001 | Dec 11, 2018 | RX | Yes | Yes | 8,921,374 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Mayne Pharma Intl | TOLSURA | itraconazole | CAPSULE;ORAL | 208901-001 | Dec 11, 2018 | RX | Yes | Yes | 9,713,642 | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Paragraph IV (Patent) Challenges for MAYNE PHARMA INTL drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Delayed-release Tablets | 150 mg | ➤ Subscribe | 2008-12-19 |
| ➤ Subscribe | Delayed-release Tablets | 200 mg | ➤ Subscribe | 2014-05-19 |
| ➤ Subscribe | Delayed-release Tablets | 50 mg | ➤ Subscribe | 2015-11-05 |
| ➤ Subscribe | Delayed-release Tablets | 200 mg | ➤ Subscribe | 2013-08-12 |
| ➤ Subscribe | Delayed-release Tablets | 80 mg | ➤ Subscribe | 2015-07-01 |
International Patents for Mayne Pharma Intl Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 2018162304 | ➤ Try a Free Trial |
| Australia | 2331801 | ➤ Try a Free Trial |
| European Patent Office | 2863911 | ➤ Try a Free Trial |
| World Intellectual Property Organization (WIPO) | 0147492 | ➤ Try a Free Trial |
| European Patent Office | 2415462 | ➤ Try a Free Trial |
| Mexico | 2015000179 | ➤ Try a Free Trial |
| Spain | 2398643 | ➤ Try a Free Trial |
| Country | Patent Number | Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
